Legend Biotech Corporation (NASDAQ:LEGN) Q4 2024 Earnings Call Transcript March 11, 2025
Legend Biotech Corporation beats earnings expectations. Reported EPS is $0.08, expectations were $-0.39.
Operator: Good day, and welcome to the Legend Biotech Fourth Quarter and Full-Year 2024 Earnings Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session, instructions will be given at that time. As a reminder, this...
